INmune Bio Inc (INMB)
5.22
+0.27
(+5.45%)
USD |
NASDAQ |
Sep 27, 16:00
5.22
0.00 (0.00%)
After-Hours: 18:36
INmune Bio Cash from Operations (Quarterly): -7.886M for June 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -7.886M |
| March 31, 2024 | -7.476M |
| December 31, 2023 | -3.401M |
| September 30, 2023 | -4.264M |
| June 30, 2023 | -3.174M |
| March 31, 2023 | -1.141M |
| December 31, 2022 | -5.695M |
| September 30, 2022 | -3.367M |
| June 30, 2022 | -4.759M |
| March 31, 2022 | -8.865M |
| December 31, 2021 | -9.78M |
| September 30, 2021 | -7.923M |
| June 30, 2021 | -5.709M |
| Date | Value |
|---|---|
| March 31, 2021 | -5.092M |
| December 31, 2020 | -2.392M |
| September 30, 2020 | -3.698M |
| June 30, 2020 | -1.818M |
| March 31, 2020 | -1.035M |
| December 31, 2019 | -0.4334M |
| September 30, 2019 | -1.946M |
| June 30, 2019 | -1.618M |
| March 31, 2019 | -1.388M |
| December 31, 2018 | -0.4624M |
| September 30, 2018 | -0.4499M |
| June 30, 2018 | -0.8178M |
| March 31, 2018 | -0.3288M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-9.78M
Minimum
Dec 2021
-0.4334M
Maximum
Dec 2019
-4.493M
Average
-3.981M
Median
Cash from Operations (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -0.578M |
| Palatin Technologies Inc | -8.607M |
| iBio Inc | -4.854M |
| Theriva Biologics Inc | -3.452M |
| Oragenics Inc | -1.544M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Financing (Quarterly) | 13.00M |
| Free Cash Flow | -23.03M |
| Free Cash Flow Per Share (Quarterly) | -0.4084 |
| Free Cash Flow Yield | -24.05% |